All Three Opioid Receptors Cloned and Characterized — A Landmark for Drug Design | Research

The takeaway

Cloned kappa, delta, and mu opioid receptors showed distinct pharmacological profiles matching decades of predictions, enabling targeted drug development.

Predictions confirmed
Decades of pharmacological predictions about three distinct opioid receptor types were validated by cloning and molecular characterization

What the researchers found

Cloned kappa, delta, and mu opioid receptors showed distinct pharmacological profiles matching decades of predictions from classical pharmacology studies.

Why it matters

Cloning and characterizing all three opioid receptors was a breakthrough that enabled targeted drug design. It confirmed the receptor subtypes that govern pain, addiction, and mood regulation.

How the study worked

Researchers expressed cloned kappa, delta, and mu opioid receptors in cell lines and performed radioligand binding studies with a panel of opioid drugs and peptides to determine receptor selectivity profiles.

What this study cannot tell us

In vitro binding studies in cell lines. Receptor behavior in isolated cells may not fully represent how receptors function in complex brain circuits with multiple interacting systems.

How to read the evidence

Strong — comprehensive in vitro characterization of cloned receptors with extensive pharmacological profiling. Foundational study.

When this study was published

Published in 1994 (32 years ago). This work is foundational — all modern opioid drug design builds on these receptor characterizations.

The bigger picture

Cloning the opioid receptors was one of neuroscience's major achievements. It transformed opioid pharmacology from observing drug effects to understanding molecular mechanisms, enabling the design of more selective, potentially safer drugs.

Questions still open

Can knowledge of receptor structure enable truly selective drugs without cross-reactivity?
Do receptor structures change in disease states?

Common questions

Why was cloning opioid receptors important?

Before cloning, scientists could only infer receptor types from drug effects. Cloning provided the actual molecular targets, enabling precise drug design, structural studies, and genetic research into pain and addiction.

How did this change drug development?

With cloned receptors, scientists could screen thousands of compounds against specific targets, design drugs with predicted selectivity, and understand at a molecular level why some drugs cause addiction while others don't.

Read the original research

Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.

Molecular pharmacology, 45(2), 330-4

View on PubMed ↗

Citation

Raynor, K; Kong, H; Chen, Y; Yasuda, K; Yu, L; Bell, G I; Reisine, T. (1994). Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.. Molecular pharmacology, 45(2), 330-4.